Treatment of APC with GPM at a dose of 300 mg/m(2) q 3 weeks was well tolerated and common toxicities were qualitatively similar to Cremophor-based paclitaxel. GPM monotherapy resulted in OS and other efficacy parameters preferable to that seen historically with gemcitabine. Future studies of GPM in combination with other agents for treatment of APC are warranted.
No takes yet. Share an insight, caveat, or question.
Saif et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: